Daurismo
(DOOR-is-moh)
A drug used with
low-dose cytarabine to treat acute myeloid leukemia that is
newly diagnosed. It is used in patients who are 75 years
and older or in patients who cannot be treated with other
anticancer drugs. It is also being studied in the treatment
of other types of cancer.
Daurismo blocks a
type of protein involved in cell growth and repair and may
block the growth of cancer cells. It is a type of hedgehog
signaling pathway antagonist. Also called glasdegib maleate.